- Posts: 7
- Thank you received: 0
1. You must be a registered website user in order to post and comment. Guests may read only.
2. Be kind and helpful, not rude and cynical.
3. Don't advertise or promote anything. You will be banned from the group.
4. Report problems to the moderators. THANK YOU!
asheducationbook.hematologylibrary.org/content/2009/1/233.full#ref-42
doi: 10.1182/asheducation-2009.1.233 ASH Education Book January 1, 2009 vol. 2009 no. 1 233-239
Antiphospholipid antibody syndrome
...
Patients with APS-associated thrombocytopenia are treated in a similar manner to patients with ITP since there are limited data suggesting that anticoagulation is an effective therapy for thrombocytopenia in these patients. Treatment options include glucocorticoids, intravenous immune globulin (IVIg), immunosuppressive agents (azathioprine, cyclophosphamide) and off-label use of newer agents such as rituximab. There are individual case reports of successful treatment of thrombocytopenia in patients with APS using danazol, aspirin, dapsone and chloroquine. ...
...
Treatment of Bleeding in Patients with APS
Bleeding is a less frequent complication than thrombosis in patients with APS. Severe thrombocytopenia can result in bleeding; less commonly, patients with APS may have antibodies directed against prothrombin, resulting in increased clearance of prothrombin and low prothrombin levels.45 The site and severity of bleeding will dictate how the bleeding is managed and how urgently this is undertaken. In general, if the bleeding results from antithrombotic therapy, the antithrombotic agent needs to be discontinued, a specific antidote administered (protamine sulfate for heparins, vitamin K for warfarin) and transfusional support given (frozen plasma for heparins or warfarin, prothrombin complex concentrates for warfarin and consideration for red cell transfusions for symptomatic anemia). If the bleeding is associated with thrombocytopenia, or if the patient is taking aspirin, platelet transfusions may be given in addition to treatments that increase the platelet count. Off-label use of recombinant factor VIIa may be considered for severe bleeding unresponsive to other therapies.
Rarely, patients with APS may present with both bleeding and thrombotic complications, and the dominant presentation or most life-threatening complication will dictate how patients are ultimately managed. Patients who are assessed to be at high risk of bleeding should have their anticoagulants withheld or anticoagulants administered using a lower intensity target range while measures to decrease bleeding should be sought. Patients who are assessed to be at high risk of thromboembolic complications despite thrombocytopenia should be anticoagulated and treatments to improve platelet count should be initiated.
www.mayoclinic.org/drugs-supplements/rituximab-intravenous-route/side-effects/drg-20068057
Check with your doctor or nurse immediately if any of the following side effects occur:
More common
Abdominal or stomach pain
black, tarry stools
bleeding gums
bloating or swelling of the face, arms, hands, lower legs, or feet
blood in the urine or stools
blurred vision
body aches or pain
chest pain
confusion
convulsions
cough or hoarseness
difficulty with breathing
dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position
drowsiness
dry mouth
ear congestion
fever and chills
flushed, dry skin
fruit-like breath odor
headache
hives or welts
increased hunger
increased thirst
increased urination
itching
large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
lower back or side pain
nausea
nervousness
noisy breathing
pain or tenderness around the eyes and cheekbones
painful or difficult urination
pale skin
pinpoint red spots on the skin
pounding in the ears
shortness of breath
skin rash
slow or fast heartbeat
sneezing
sore throat
sores, ulcers, or white spots in the mouth or on the lips
stuffy or runny nose
sweating
swelling of the tongue or throat
swollen glands
tightness of the chest
tingling of the hands or feet
troubled breathing with exertion
unusual bleeding or bruising
unusual tiredness or weakness
unusual weight gain or loss
vomiting
Less common
Blistering, peeling, or loosening of the skin
blisters in the mouth
blisters on the trunk, scalp, or other areas
burning, crawling, itching, numbness, prickling, “pins and needles”, or tingling feeling
burning, tingling, numbness or pain in the hands, arms, feet, or legs
decreased frequency and amount of urination
diarrhea
difficulty with moving
discouragement
feeling sad or empty
irregular heartbeat
irritability
joint or muscle pain
loss of appetite
loss of interest or pleasure
muscle cramps
muscle pain or stiffness
numbness or tingling in the hands, feet, or lips
pain at the injection site
pain, swelling, or redness in the joints
red skin lesions, often with a purple center
red, itchy lining of the eye
redness of the face, neck, arms, and occasionally, upper chest
stabbing pain
trouble concentrating
trouble sleeping
Incidence not known
Abdominal or stomach cramps
blue-yellow color blindness
blurred vision or other change in vision
burning or stinging of the skin
decreased vision
dilated neck veins
dry cough
extreme fatigue
eye pain, tearing
feeling of discomfort, illness, or weakness
irregular breathing
nosebleed
painful cold sores or blisters on the lips, nose, eyes, or genitals
sensitivity of the eye to light
severe abdominal or stomach pain
severe vomiting, sometimes with blood
sores, welting, or blisters
swelling, stiffness, redness, or warmth around many joints
swollen and inflamed joints
swollen lymph glands
vision loss
The Platelet Disorder Support Association does not provide medical advice or endorse any medication, vitamins or herbs. The information contained herein is not intended nor implied to be a substitute for professional medical advice and is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider before starting any new treatment, discontinuing an existing treatment and to discuss any questions you may have regarding your unique medical condition.
Platelet Disorder Support Association
8751 Brecksville Road, Suite 150, Cleveland, Ohio 44141
Phone: 1-87-PLATELET | 877-528-3538 (toll free) | or 440-746-9003
E-mail: pdsa@pdsa.org
© Copyright 1997 - 2025, Platelet Disorder Support Association. All rights reserved.
The Platelet Disorder Support Association is a 501(c)3 organization and donations are tax deductible to the fullest extent allowed by law.